The treatment options for sepsis are limited in scope and efficacy, resulting in frequent human fatalities. Liew and colleagues now report that interleukin-33 is a promising therapeutic strategy that increases neutrophil recruitment to the site of infection and bacterial clearance and decreases mortality in a mouse model of sepsis.
- Jose C Alves-Filho
- Fabiane Sônego
- Foo Y Liew
